Over 200 sea sponges were tested and a compound that caused changes in cells extracted from Parkinson's disease patients was identified, scientists at Queensland's Griffith University were quoted as saying by a ABC news report.
Using a new method, the researchers are testing over 200,000 natural compounds.
"The results are promising, but there are more than 200,000 samples left to test," researcher Ronald Quinn said.
"We've developed a technique using spectroscopy to look for something that's novel, so that part of it gives us a compound that has not been found previously by anyone else, so it's unique," he said.
"When we looked at those 220 using this MMR fingerprinting, that allowed us to see which of those 220 had an unique component and that really allowed us to hone, and isolate and identify this compound that's new," Quinn said.
The technique could be used to treat a variety of conditions, but is a way off yet.
"In this study if we get one [compound] out of 200 - and we have 200,000 - that's quite a lot of potential that we can find that may help in trying to understand Parkinson's disease in this particular program," Quinn said, adding it is a tool to try to understand the biology behind the Parkinson's disease.
"Any therapeutic use or drug use is well down the track. We're trying to find within that haystack if you like - the needle - the single compound that's quite unique and different and can be useful to be developed towards understanding the disease, and then later on to try to treat the disease," he said.
"Because it's producing chemicals for protection and other functions, then those compounds may be useful in a therapeutic sense on a human target," he said.
You’ve reached your limit of 10 free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app